KK
Keshri Kant Mishra
About Keshri Kant Mishra
Data last updated:
Keshri Kant Mishra is a Director at Parnasa Mediworld Private Limited (since 2016) and Director at Biomodex Pharmaceuticals Private Limited (since 2019). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹16.87 Cr; the largest is Parnasa Mediworld Private Limited at ₹12.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parnasa Mediworld Private Limited U51397DL2016PTC292781 | Director | 17 Mar 2016 | 2016 | ₹12.86 Cr (FY 2025) | Active |
 Biomodex Pharmaceuticals Private Limited U24290DL2019PTC348128 | Director | 01 Apr 2019 | 2019 | ₹4.02 Cr (FY 2025) | Active |
Board colleagues of Keshri Kant Mishra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kanak Kant Mishra | 07474096 | Parnasa Mediworld Private Limited | Director |
| Gayatri Mishra | 08409049 | Biomodex Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Keshri Kant Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keshri Kant Mishra
Keshri Kant Mishra currently holds 2 directorships: Parnasa Mediworld Private Limited (Director, since 17 Mar 2016, revenue ₹12.86 Cr (FY 2025)); Biomodex Pharmaceuticals Private Limited (Director, since 01 Apr 2019, revenue ₹4.02 Cr (FY 2025)).
Keshri Kant Mishra was first appointed on 17 Mar 2016 as Director at Parnasa Mediworld Private Limited. The most recent appointment on record is 01 Apr 2019 at Biomodex Pharmaceuticals Private Limited.
The 2 current companies of Keshri Kant Mishra that report revenue have a combined latest revenue of ₹16.87 Cr: Parnasa Mediworld Private Limited ₹12.86 Cr (FY 2025); Biomodex Pharmaceuticals Private Limited ₹4.02 Cr (FY 2025).
The current boards of Keshri Kant Mishra's companies include Kanak Kant Mishra (Parnasa Mediworld Private Limited), Gayatri Mishra (Biomodex Pharmaceuticals Private Limited).